Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Pharmacology of LT5001 Drug Product in Hemodialysis Patients With Uremic Pruritus to Assess the Safety, Local Tolerance and Pharmacokinetics

NCT04393675 is registered in ClinicalTrials.gov with Lumosa Therapeutics Co., Ltd. as lead sponsor.

NCT NCT04393675
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04393675 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Pharmacology of LT5001 Drug Product in Hemodialysis Patients With Uremic Pruritus to Assess the Safety, Local Tolerance and Pharmacokinetics
Lead sponsor
Lumosa Therapeutics Co., Ltd.
Phase
Phase 1/2
Overall status
Terminated
Start date
May 14, 2020
Completion date
September 15, 2022
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

uremic pruritus